financetom
Business
financetom
/
Business
/
Ingevity Licenses CHASM Advanced Materials' Carbon Nanotube Production Technology
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ingevity Licenses CHASM Advanced Materials' Carbon Nanotube Production Technology
Nov 11, 2025 5:22 AM

07:46 AM EST, 11/11/2025 (MT Newswires) -- Ingevity ( NGVT ) has signed a license agreement for CHASM Advanced Materials' carbon nanotube production technology, CHASM said Tuesday.

Ingevity ( NGVT ) now has the rights to manufacture CHASM's NTeC-E carbon nanotube conductive additives for battery applications in North America and select countries in Europe, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ginkgo Bioworks Holdings Insider Bought Shares Worth $514,750, According to a Recent SEC Filing
Ginkgo Bioworks Holdings Insider Bought Shares Worth $514,750, According to a Recent SEC Filing
May 16, 2024
05:11 PM EDT, 05/16/2024 (MT Newswires) -- Shyam Sankar, Director, on May 15, 2024, executed a purchase for 625,000 shares in Ginkgo Bioworks Holdings ( DNA ) for $514,750. Following the Form 4 filing with the SEC, Sankar has control over a total of 2,356,874 shares of the company, with 2,356,874 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1830214/000112760224015703/xslF345X03/form4.xml ...
Arcosa Insider Sold Shares Worth $973,833, According to a Recent SEC Filing
Arcosa Insider Sold Shares Worth $973,833, According to a Recent SEC Filing
May 16, 2024
05:11 PM EDT, 05/16/2024 (MT Newswires) -- Kerry S Cole, Group President, on May 15, 2024, sold 10,978 shares in Arcosa ( ACA ) for $973,833. Following the Form 4 filing with the SEC, Cole has control over a total of 18,527 shares of the company, with 18,527 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1739445/000173944524000098/xslF345X03/wk-form4_1715893617.xml ...
Ani Pharmaceuticals Insider Sold Shares Worth $1,101,821, According to a Recent SEC Filing
Ani Pharmaceuticals Insider Sold Shares Worth $1,101,821, According to a Recent SEC Filing
May 16, 2024
05:08 PM EDT, 05/16/2024 (MT Newswires) -- Nikhil Lalwani, Director, President & CEO, on May 14, 2024, sold 16,669 shares in Ani Pharmaceuticals ( ANIP ) for $1,101,821. Following the Form 4 filing with the SEC, Lalwani has control over a total of 377,505 shares of the company, with 377,505 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1023024/000182262924000010/xslF345X03/wk-form4_1715893316.xml ...
NYCB's chief operating officer to step down
NYCB's chief operating officer to step down
May 16, 2024
(Reuters) - Embattled lender New York Community Bancorp ( NYCB ) said on Thursday that its Chief Operating Officer Julie-Ann Signorille-Browne has resigned from her role, effective May 24. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved